item1.txt
The Company is currently evaluating the impact of the adoption of ASU 2017-12 on its consolidated financial 
The new guidance primarily impacts the income statement presentation of net periodic benefit cost and the Company does not believe adoption of this standard will have a material impact on its consolidated financial statements including income before income taxes, but the reported amount of operating income will decrease compared to historical measurements of operating income.
The Company is currently evaluating the impact of the adoption of ASU 2016-02 on its consolidated financial statements.
ASU 2014-09 is required to be adopted by the Company in the first quarter of fiscal 2019.
The Company expects to adopt the requirements of ASU 2014-09 using retrospective adoption to each prior reporting period presented.
The impact of this acquisition was not material to the Company’s consolidated balance sheets or statements of operations.
Included in the gain on sale recorded upon completion of the sale were estimates for certain income taxes due on the gain and additional cash consideration expected from the Buyer related to a closing date net working capital sales price adjustment (the “closing date adjustment”).
The Company is finalizing the closing date adjustment with the Buyer as provided for in the sales agreement and has included an estimate of this amount as primary component of the $305.1 million of prepaid and other current assets as of March 31, 2018.
During the third quarter of fiscal 2018, the Company made certain adjustments to the closing date estimates, which were not material and have been included as an adjustment to the gain on sale of discontinued operations classified within “Income (loss) from discontinued operations, net of tax” on the Consolidated Statements of Operations.
The income taxes associated with the gain will be impacted by the final geographic allocation of the sales price, which must be agreed to with the Buyer after determination of the closing date adjustment, as required in the sales agreement, and may be materially different from the Company’s estimates.
The Company currently expects the closing date adjustment to be finalized by the first half of fiscal 2019 and the income tax on the gain to be finalized by the end of fiscal 2019.
The Company received 2.8 million shares of the Buyer’s common stock at closing (the “Shares”), which has been recorded within “Marketable securities” on the Company’s Consolidated Balance Sheets.
As of March 31, 2018, the Company had 0.9 million shares remaining, which had market value of $75.1 million.
Unrealized and realized gains or losses due to changes in fair value based upon Level 1 quoted active market prices of the Shares are recorded in “Other income (expense), net” on the Consolidated Statements of Operations.
The sales agreement includes time based contractual restrictions related to the Company’s sale of the Shares and as such, the Company entered into economic hedges to reduce the Company’s exposure to price fluctuations of the Shares during the restricted period, which fixes the net amount that the Company will realize upon the sale of the Shares.
The Company records changes in fair value related to the economic share price hedges within “Other income (expense), net”, offsetting the changes in fair value of the underlying Shares.
During the nine months ended March 31, 2018, the Company sold 1.9 million Shares, the net proceeds of which have been included in “Cash flows from investing activities – discontinued operations.”  
In connection with the sale of the TS business, the Company entered into a Transition Services Agreement (“TSA”), pursuant to which the Buyer will pay the Company to provide certain information technology, distribution, facilities, finance and human resources related services for various periods of time depending upon the services not to exceed approximately two years from the closing date.
Included within selling, general and administrative expenses of discontinued operations was $8.3 million and $34.9 million of estimated corporate expenses, excluding general overhead, specific to or benefiting the TS business for the third quarter and nine months ended April 1, 2017, respectively.
The loss from discontinued operations, net of tax, in the third quarter and first nine months of fiscal 2018 substantially all relates to settlement losses associated with the Company’s pension plan due to former TS business employees requesting and receiving distributions from the Company’s pension plan during fiscal 2018 and the closing date adjustments discussed above.
In the third quarter of fiscal 2018, in conjunction with the commencement of the Company’s annual long-term planning process, it became apparent that lower cash flows are expected from the Americas over such planning horizon compared to prior year long-term cash flow expectations.
As a result of the lower expected cash flows as well as certain other factors, the Company concluded that an interim quantitative goodwill impairment test for the Americas was necessary in the third quarter of fiscal 2018.
In assessing the Americas goodwill for impairment in the third quarter of fiscal 2018, the Company was required to make significant judgments related to the fair value of the Americas.
As a result of the impairment testing and related fair value estimate of the Americas in the third quarter of fiscal 2018, the Company impaired all of the goodwill in the Americas and recorded $181.4 million of goodwill impairment expense, which is classified within goodwill impairment expense in the Consolidated Statements of Operations.
Bank credit facilities and other consists primarily of various committed and uncommitted lines of credit and other forms of bank debt with financial institutions utilized primarily to support the working capital requirements of the Company including its foreign operations.
The Company adjusts any economic hedges to fair value through the consolidated statements of operations primarily within “other income (expense), net.” The fair value of forward foreign exchange contracts, which are based upon Level 2 criteria under the ASC 820 fair value hierarchy, are classified in the captions “other current assets” or “accrued expenses and other,” as applicable, in the accompanying consolidated balance sheets as of March 31, 2018, and July 1, 2017.
The above table excludes approximately $35.0 million of loss for the first nine months of fiscal 2017, of derivative financial instrument losses in other income (expenses), net, associated with foreign currency derivative financial instruments purchased to economically hedge the British Pound purchase price of the PF acquisition.
As of March 31, 2018 and July 1, 2017, the Company had aggregate estimated liabilities of $14.2 million, classified within accrued expenses and other for such compliance-related matters that were reasonably estimable as of such dates.
During the second quarter of fiscal year 2018, the Company recorded a provisional expense to account for the deferred tax impacts of the Act, which remained unchanged as of March 31, 2018.
During the first nine months of fiscal 2017, the Company’s effective tax rate of 25.7% was favorably impacted primarily by (i) the mix of income in lower tax jurisdictions, partially offset by (ii) net increases to valuation allowances against deferred tax assets that were deemed unrealizable and (iii) the impact of non-deductible acquisition related expenses.
The Company contributed $12.0 million to the Plans during the first nine months of fiscal 2018 and expects to make an additional contribution to the Plans of $4.0 million in the fourth quarter of fiscal 2018.
Amounts reclassified out of accumulated other comprehensive income (loss), net of tax, to operating expenses during the third quarters and the first nine months of fiscal 2018 and fiscal 2017 were substantially all related to net periodic pension costs including recognition of actuarial losses and amortization of prior service credits.
As a result, the Company recognized a $4.9 million and $18.9 million of pension settlement expenses before taxes in the third quarter and first nine months of fiscal 2018, respectively, classified within income (loss) from discontinued operations.
During the third quarter and nine months ended March 31, 2018, the Company repurchased 1.7 million and 5.3 million shares, respectively, under this program for a total cost of $70.0 million and $209.5 million, respectively.
As of March 31, 2018, the Company had $389.6 million remaining under its share repurchase authorization.
During the nine months ended March 31, 2018, the Company paid dividends of $0.55 per common share and $66.2 million in total.
(4)Includes sales from China (including Hong Kong), Taiwan and Singapore of $645.3 million, $616.7 million and $231.6 million, respectively, for the third quarter ended March 31, 2018, and $1.94 billion, $1.99 billion and $677.8 million, respectively, for the first nine months of fiscal 2018.
Based on the information known to date, management believes that the Company has appropriately accrued in its consolidated financial statements for its share of the estimable costs of environmental and other compliance related matters.


item2.txt
Sales for the third quarter of fiscal 2018 were $4.80 billion, an increase of 8.0%, or $353.2 million, from the prior year third quarter sales of $4.44 billion.
EC sales of $4.40 billion in the third quarter of fiscal 2018 increased $313.2 million or 7.7% from the prior year third quarter sales of $4.09 billion.
PF sales for the third quarter of fiscal 2018 were $391.0 million, an increase of $40.0 million or 11.4% from the prior year third quarter sales of $351.0 million driven by growth in all three regions including the benefit from the weakening U.S. Dollar.
This increase was primarily due to the acquisition of PF, which was acquired in the second quarter of fiscal 2017, and an overall increase in sales in EC as double-digit growth in the EMEA and Asia regions of EC offset a year to date decrease of 8.9% in the EC Americas region.
Organic sales for the first nine months of 2018 increased $765.8 million, or 5.8%, compared to the first nine months of fiscal 2017 primarily due to double-digit sales growth in EMEA and Asia regions, offset by a decline of 7.9% in the Americas region.
As a result of the interim impairment testing and related fair value estimate of the Americas as of the third quarter of fiscal 2018, the Company impaired all of the goodwill in the Americas and recorded $181.4 million of goodwill impairment expense in the third quarter of fiscal 2018.
The Company recorded restructuring, integration and other expenses of $25.1 million during the third quarter of fiscal 2018.
The Company recorded $5.9 million of restructuring costs in the third quarter of fiscal 2018 in order to realize approximately $7.2 million in expected annualized operating cost savings once such restructuring actions initiated before the end of the third quarter of fiscal 2018 are completed.
During the third quarter of fiscal 2018, the Company incurred integration costs of $2.5 million, accelerated depreciation of $13.1 million, other costs of $3.2 million and an expense of $0.4 million for changes in estimates for costs associated with prior year restructuring actions.
Comparatively, in the third quarter of fiscal 2017, restructuring, integration and other expenses from continuing operations were $35.5 million.
In the first nine months of fiscal 2017, restructuring, integration and other expenses from continuing operations was $95.4 million.
Adjusted operating income for the third quarter of fiscal 2018 was $174.9 million, an increase of $2.6 million, or 1.5%, from the third quarter of fiscal 2017.
Operating income for the first nine months of fiscal 2018 was $102.6 million, or 0.7% of consolidated sales, as compared with operating income of $368.0 million, or 2.9% in the first nine months of 2017 primarily driven by declines in EC partially offset by the acquisition of PF.
During the third quarter of fiscal 2018, the Company had $8.4 million of other income, net, as compared with $19.4 million of other income, net, in the third quarter of fiscal 2017.
During the first nine months of fiscal 2018, the Company had $24.7 million of other income, net, as compared with $30.8 million of other expense, net, in the first nine months of fiscal 2017.
In the third quarter and first nine months of fiscal 2018, the Company had foreign currency gains primarily due to the weakening of the U.S. Dollar.
In the third quarter of fiscal 2017, the Company had other income due to unrealized gains on marketable securities obtained through the sale of TS.
See Note 8 “Income taxes” to the Company’s consolidated financial statements included in this Quarterly Report on Form 10-Q for further information including discussion of the provisional transition tax expense estimate recorded under the requirements of the Act in the third quarter of fiscal 2018.
Loss from discontinued operations was $(4.5) million and $(14.4) million in the third quarter and the first nine months of fiscal 2018, respectively, primarily as a result of settlement losses associated with the Company’s pension plan due to former TS business employees requesting and receiving distributions from the Company’s pension plan during fiscal 2018.
Income from discontinued operations was $181.9 million and $253.8 million in the third quarter and the first nine months of fiscal 2017, respectively, due to the operating results of the TS business, which was sold in the third quarter of fiscal 2017.
Included in the income from discontinued operations in the third quarter and first nine months of fiscal 2017, was $217.1 million for the estimated gain on sale of TS, net of taxes.
Cash used for operating activities of discontinued operations was $325.1 million in the first nine months of fiscal 2017 as the sale of the TS business was completed in the third quarter of fiscal 2017.
During the first nine months of fiscal 2018, the Company used $112.2 million for capital expenditures primarily related to information system development costs, computer hardware and software purchases and facilities costs compared to $108.0 million for capital expenditures in the first nine months of fiscal 2017.
During the first nine months of fiscal 2018, the Company generated $153.9 million of cash from investing activities – discontinued operations as a result of the sale of marketable securities obtained through the sale of the TS business.
The Company used $98.5 million in cash flows from operating activities over the trailing four fiscal quarters ended March 31, 2018 for continuing operations.
The following table includes the Company’s monthly purchases of the Company’s common stock during the third quarter of fiscal 2018, under the share repurchase program, which is part of a publicly announced plan.


item3.txt
The Company continues to have exposure to such risks to the extent they are not economically hedged.


part2.txt
As a result primarily of certain former manufacturing operations, Avnet has incurred and may have future liability under various federal, state and local environmental laws and regulations, including those governing pollution and exposure to, and the handling, storage and disposal of, hazardous substances.
For example, under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and similar state laws, Avnet is and may be liable for the costs of cleaning up environmental contamination on or from certain of its current or former properties, and at off-site locations where the Company disposed of wastes in the past.
Pursuant to SEC regulations, including but not limited to Item 103 of Regulation S-K, the Company regularly assesses the status of and developments in pending environmental and other compliance related legal proceedings to determine whether any such proceedings should be identified specifically in this discussion of legal proceedings, and has concluded that no particular pending legal proceeding requires public disclosure.


